Medartis Holding AG (XSWX:MED) 6-Month Price Index: 0.99 (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:MED Medartis Holding AG XSWX:MED
87 GF Score
Price CHF93.50
GF Value CHF106.40
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Medartis Holding AG 6-Month Price Index?

Medartis Holding AG XSWX:MED 87 6-Month Price Index is 0.99 as of Aug. 20, 2026. GuruFocus rates XSWX:MED with a GF Score™ of 87/100 and a GF Value™ of CHF106.40 (Modestly Undervalued). The stock has 6 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-08-20), Medartis Holding AG's 6-Month Price Index is 0.99.

Medartis Holding AG  (XSWX:MED) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Medartis Holding AG 6-Month Price Index Related Terms

XSWX:MED vs ABT, SYK, MDT: 6-Month Price Index Comparison

For the Medical Devices subindustry, Medartis Holding AG's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XSWX:MED
87GF Score
Medartis Holding AG XSWX:MED
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medartis Holding AG  (XSWX:MED) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 0.99 mean?
Medartis Holding AG (XSWX:MED) has a 6-Month Price Index of 0.99 as of Aug. 20, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Medartis Holding AG and its competitors.
Is Medartis Holding AG's 6-Month Price Index too high?
Medartis Holding AG's current 6-Month Price Index is 0.99. Overall, Medartis Holding AG has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's 6-Month Price Index compare to ABT and SYK?
Medartis Holding AG's 6-Month Price Index of 0.99 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Medical Devices & Instruments company?
A good 6-Month Price Index depends on the Medical Devices & Instruments industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Medartis Holding AG and its competitors. Medartis Holding AG's current 6-Month Price Index is 0.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF106.40, compared to a current price of CHF93.50 — trading 12.1% below its estimated fair value. The current 6-Month Price Index is 0.99. Medartis Holding AG's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current 6-Month Price Index is 0.99 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued. The current stock price of CHF93.50 is trading 12.1% below its estimated GF Value™ of CHF106.40. GuruFocus considers Medartis Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:MED:

  • 6-Month Price Index: 0.99
  • GF Value™: CHF106.40 vs. price of CHF93.50 (12.1% below fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medartis Holding AG Business Description

Other Exchanges MEDz:UK1RU:Germany
Address Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
87GF Score

Get the complete analysis for XSWX:MED

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF93.50
Price
CHF106.40
GF Value